Shinohara, Mari L.
- Duke University · Microbiology & Immunology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #11,373
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2011 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Microbiology & Immunology
NIH Funding · FY2023
Linked Award Amount
$918.8K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#11,373
By linked amount among FY2023 PIs
Earliest Year Loaded
2011
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Shinohara, Mari L. as a PI. Multi-PI records show the full award amount for context.
- 5R01AI160737-03R01Contact PIHeterogeneous immune responses of the alveolar macrophage population during pulmonary fungal infectionsDuke University · Microbiology & Immunology (NIH department code)$517.8Kaward amount
- 5R01NS120417-03R01Contact PIProtective role of Clec7a/dectin-1 in CNS autoimmunityDuke University · Microbiology & Immunology (NIH department code)$400.9Kaward amount
Award organization
Organizations that administered FY2023 awards listing Shinohara, Mari L. as a PI.
FY2023 award administered by Duke University (NC).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2011First NIH AwardDuke University
- 2012$500K Cumulative Funding
- 2013$1M Cumulative Funding
- 2015$2M Cumulative Funding
- 2015R01 Grant Holder
- 2021$5M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #5967